Pharmaceutical compositions comprising trimegestone

Details Pharmaceutical compositions comprising trimegestone Pharmaceutical compositions comprising trimegestone

2006-09-18

2010-06-08

Padmanabhan, Sreeni (Department: 1627)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S169000, C514S177000, C514S182000

Reexamination Certificate

active

07732431

ABSTRACT:
The invention concerns a pharmaceutical composition comprises trimegestone optionally associated with an oestrogen, characterized in that it comprises a buffer solution whereof the pH, when it is introduced in the composition, ranging essentially between 2 and 5.5. The invention also concerns the methods for making such a composition and the primary package containing them.

REFERENCES:
patent: 4087581 (1978-05-01), Vincent et al.
patent: 4761406 (1988-08-01), Flora et al.
patent: 5382434 (1995-01-01), de Haan et al.
patent: 5384419 (1995-01-01), Buendia et al.
patent: 5399685 (1995-03-01), Buendia et al.
patent: 5547948 (1996-08-01), Barcomb
patent: 5759577 (1998-06-01), Barcomb et al.
patent: 5834452 (1998-11-01), Biton et al.
patent: 5858405 (1999-01-01), Gast et al.
patent: 6004477 (1999-12-01), Nakagawa et al.
patent: 6063403 (2000-05-01), de Haan et al.
patent: 6329416 (2001-12-01), Grubb et al.
patent: WO 98/04269 (1998-02-01), None
McIlvaine buffer document (Whetten Ross, 1997).

Affiliated with

Also associated with

Rating

Pharmaceutical compositions comprising trimegestone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions comprising trimegestone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising trimegestone will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4248823